THERAPY OF P53 MUTANT COLON ADENOCARCINOMA, BREAST CANCER AND LUNG CANCER

摘要

The present invention provides a method for treating a hyperproliferative disorder characterized by expression of a mutant form of p53 in a subject, the method comprising administering to the subject a therapeutically effective amount of an agent which inhibits promyelocytic leukemia (PML) protein.